Drug Repurposing for Triple-Negative Breast Cancer

Drug Repurposing for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer which presents a high rate of relapse, metastasis, and mortality. Nowadays, the absence of approved specific targeted therapies to eradicate TNBC remains one of the main challenges in clinical practice. Drug discovery...

Full description

Bibliographic Details
Main Authors: Marta Ávalos-Moreno, Araceli López-Tejada, Jose L. Blaya-Cánovas, Francisca E. Cara-Lupiañez, Adrián González-González, Jose A. Lorente, Pedro Sánchez-Rovira, Sergio Granados-Principal
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Personalized Medicine
Subjects:
triple-negative breast cancer
personalized medicine
computational methods
drug repurposing
clinical trials
cancer stem cells
Online Access:https://www.mdpi.com/2075-4426/10/4/200

Similar Items

Similar Items